sitafloxacin fumarate (Nanjing Yoko Pharmaceutical)

N/A

Report date: 2026/03/20 09:47:06
NME

Base Information

Drug Namesitafloxacin fumarate (Nanjing Yoko Pharmaceutical)
Drug Alias NamesitafloxacinYK-2001
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics
Mechanisms of ActionBacterial DNA gyrase inhibitorsTopoisomerase IV inhibitors
TargetsBacterial DNA gyraseTopoisomerase IV
Therapy Area/IndicationsPyelonephritisUrinary Tract InfectionsPneumonia, Bacterial +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesNanjing Yoko Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNanjing Libowei Pharmaceutical Co LtdNanjing Yoko Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsPyelonephritisUrinary Tract InfectionsPneumonia, Bacterial +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A